• Libraries
    • Log in to:
    View Item 
    •   MSpace Home
    • Rady Faculty of Health Sciences
    • College of Medicine - B.Sc. (Med) Projects
    • View Item
    •   MSpace Home
    • Rady Faculty of Health Sciences
    • College of Medicine - B.Sc. (Med) Projects
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Carboplatin and Paclitaxel versus Doxorubicin and Cisplatin for Carcinosarcoma of the Uterus: A historical cohort with control based on FIGO 2009 criteria from the University of Manitoba

    Thumbnail
    View/Open
    Barnard_A_BScMed_2011.pdf (266.4Kb)
    Date
    2012-03-12
    Author
    Barnard, Alicia
    Metadata
    Show full item record
    Abstract
    Objectives: To compare two different chemotherapy adjuvant treatment regimens currently and previously used at CancerCare Manitoba for endometrial carcinosarcoma. Methods: This is a retrospective analysis of 60 patients diagnosed with primary endometrial carcinosarcoma at CancerCare Manitoba from 1998-2008. The demographic characteristics, malignancy stage, presence of recurrent disease, and treatment type(s) utilized were studied. 37 patients were found to have received either carboplatin/paclitaxel or doxorubicin/cisplatin for carcinosarcoma, and were further analyzed to determine if there was a statistically significant difference in progression-free survival and overall survival between the two treatments. Kaplan-Meier curves were used to display progression-free survival and overall survival. Results: 60.4% of patients presented with low-stage disease. No statistically significant difference in progression-free survival or overall survival between the two cohorts was found. Recurrence rate was 31.7%. The mean time to recurrence in the combined cohorts was 23.2 months. 16.7% of the patients had or were currently being treated with tamoxifen. 73.7% of patients having recurrence did not undergo lymph node dissections and 100% of patients with local recurrence were treated with vaginal vault brachytherapy. Conclusions: Due to the rarity of this malignancy, multi-centre studies are warranted based on the data collected as sample sizes were too small for statistical significance. Further investigations towards optimizing treatment and understanding disease associations should be performed in the future to help better manage these patients and improve survival.
    URI
    http://hdl.handle.net/1993/5151
    Collections
    • College of Medicine - B.Sc. (Med) Projects [206]

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of MSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV